Physician

John Thomas Frisbee, MD

According to 2025 Medicare claims, John Frisbee, MD (NPI: 1437358868) practices ophthalmology in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is EYE ASSOCIATES LLC (NPI: 1124071717; TIN: 721476463) and primary practice location at 70458-2724.

Frisbee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 451 traditional Medicare patients, billed 52,678 HCPCS/CPT codes, and received $2,378,439 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 348 prescription claims across 123 beneficiaries totaling $15,923 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 16 records totaling $530. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,209,079 to $2,378,439. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2015 Medicare payment: $1,209,079 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,193,544 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,148,525 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,108,865 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,197,142 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,248,503 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,485,996 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,551,611 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,110,519 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,378,439 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201562910,726$1,209,079
201665412,123$1,193,544
201764610,916$1,148,525
20185819,705$1,108,865
20195539,235$1,197,142
20205206,499$1,248,503
20214217,595$1,485,996
20224359,893$1,551,611
202343653,699$2,110,519
202445152,678$2,378,439

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$44K$89K2015 Drug cost: $20,372 (USD; Tot_Drug_Cst)2016 Drug cost: $23,337 (USD; Tot_Drug_Cst)2017 Drug cost: $32,127 (USD; Tot_Drug_Cst)2018 Drug cost: $53,360 (USD; Tot_Drug_Cst)2019 Drug cost: $88,572 (USD; Tot_Drug_Cst)2020 Drug cost: $75,573 (USD; Tot_Drug_Cst)2021 Drug cost: $21,972 (USD; Tot_Drug_Cst)2022 Drug cost: $19,580 (USD; Tot_Drug_Cst)2023 Drug cost: $22,195 (USD; Tot_Drug_Cst)2024 Drug cost: $15,923 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201570178$20,372
201684232$23,337
2017107301$32,127
2018134461$53,360
2019175595$88,572
2020145488$75,573
202193248$21,972
202296247$19,580
202388265$22,195
2024123348$15,923

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system276280$90
92012Established patient problem focused exam of visual system3561,141$66
92134Imaging of retina4421,449$29
92250Photography of the retina4381,333$27
92285Photography of content of eyes388553$16

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1675,984$7,509
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat513,155$677
Brimonidine TartrateBrimonidine Tartrate13768$626
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha14184$176
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1744$84

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$530Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Thomas Frisbee, MD?

Tedicare shows public-source Medicare data for John Thomas Frisbee, MD (NPI 1437358868), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Thomas Frisbee, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Thomas Frisbee, MD?

John Thomas Frisbee, MD is linked to EYE ASSOCIATES LLC (billing NPI 1124071717) in the available physician profile data.

Does John Thomas Frisbee, MD have Open Payments data?

John Thomas Frisbee, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.